Pds Biotech Announces Acceptance Of Abstract On Combination Of Pds0301 With Docetaxel In Metastatic Prostate Cancer For Oral Presentation By The National Cancer Institute At Cytokines 2023

Media coverage

• Title	Pds Biotech Announces Acceptance Of Abstract On Combination Of Pds0301 With Docetaxel In Metastatic Prostate Cancer For Oral Presentation By The National Cancer Institute At Cytokines 2023
  Media name/outlet	MENAFN -Press Releases (English)
  Country/Territory	Jordan
  Date	17/07/23
  Persons	William Figg